-
公开(公告)号:US20090298811A1
公开(公告)日:2009-12-03
申请号:US12440646
申请日:2007-09-03
申请人: Kazuo Ando , Ingrid Price Buchler , Shridhar Gajanan Hedge , Makoto Kawai , Tsutomu Masuda , Hirofumi Omura
发明人: Kazuo Ando , Ingrid Price Buchler , Shridhar Gajanan Hedge , Makoto Kawai , Tsutomu Masuda , Hirofumi Omura
IPC分类号: A61K31/55 , A61K31/5377 , A61K31/4965 , A61K31/437 , A61K31/4245 , A61K31/4184 , C07D405/14 , C07D413/06 , C07D403/08 , C07D471/04 , C07D413/12 , C07D235/24
CPC分类号: C07D413/06 , A61K31/16 , C07D235/26 , C07D401/06 , C07D403/06 , C07D403/12 , C07D405/06 , C07D413/12 , C07D413/14 , C07D471/04
摘要: This invention relates to compounds and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective amount of the compound of formula (I) or pharmaceutically acceptable salts thereof, wherein: A, B, R1, R2 and R3 are each as described herein. These compounds are useful in the treatment of a condition mediated by CB2 receptor binding activity such as, but not limited to, inflammatory pain, nociceptive pain, neuropathic pain, fibromyalgia, chronic low back pain, visceral pain, acute cerebral ischemia, pain, chronic pain, acute pain, post herpetic neuralgia, neuropathies, neuralgia, diabetic neuropathy, HIV-related neuropathy, nerve injury, rheumatoid arthritic pain, osteoarthritic pain, back pain, cancer pain, dental pain, fibromyalgia, neuritis, sciatica, inflammation, neurodegenerative disease, spasticity, epilepsy, Tourette's syndrome, Parkinson's disease, neuroprotection, anxiety, cough, broncho constriction, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), colitis, cerebrovascular ischemia, cachexia, nausea, emesis, chemotherapy-induced emesis, rheumatoid arthritis, asthma, Crohn's disease, ulcerative colitis, asthma, dermatitis, seasonal allergic rhinitis, gastroesophageal reflux disease (GERD), constipation, diarrhea, functional gastrointestinal disorder, cutaneous T cell lymphoma, multiple sclerosis, osteoarthritis, psoriasis, systemic lupus erythematosus, diabetes, glaucoma, osteoporosis, glomerulonephritis, renal ischemia, nephritis, hepatitis, cerebral stroke, vasodialation, hypertension, vasculitis, myocardial infarction, cerebral ischemia, reversible airway obstruction, adult respiratory disease syndrome, chronic obstructive pulmonary disease (COPD), cryptogenic fibrosing alveolitis and bronchitis.
-
公开(公告)号:US20110028447A1
公开(公告)日:2011-02-03
申请号:US12918914
申请日:2009-02-26
申请人: Ingrid Price Buchler , Michael Joseph Hayes , Shridhar Gajanan Hegde , Susan Landis Hockerman , Darin Eugene Jones , Steven Wade Kortum , Joseph Gerace Rico , Ruth Elizabeth TenBrink , Kun Ken Wu
发明人: Ingrid Price Buchler , Michael Joseph Hayes , Shridhar Gajanan Hegde , Susan Landis Hockerman , Darin Eugene Jones , Steven Wade Kortum , Joseph Gerace Rico , Ruth Elizabeth TenBrink , Kun Ken Wu
IPC分类号: A61K31/541 , C07D231/56 , C07D413/06 , C07D401/06 , C07D401/10 , C07D413/12 , C07D471/04 , C07D413/10 , C07D405/12 , C07D403/12 , C07D401/12 , C07D417/12 , A61P29/00 , A61K31/416 , A61K31/422 , A61K31/4439 , A61K31/4245 , A61K31/437 , A61K31/41 , A61K31/5377 , A61K31/454 , A61K31/496 , A61K31/4178 , A61K31/513 , A61K31/4196 , A61K31/4192 , A61K31/427 , A61K31/433
CPC分类号: C07D231/56 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/04 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D487/04 , C07D487/08
摘要: This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective amount of the compound of formula (I) wherein R1, R2 and R3 are as defined in this specification.
摘要翻译: 本发明涉及用于治疗哺乳动物受试者(包括人)中由CB1受体活性介导的病症的化合物,药物组合物和方法,其包括向需要这种治疗的哺乳动物施用治疗有效量的式( I)其中R1,R2和R3如本说明书中所定义。
-